SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-040115
Filing Date
2023-11-09
Accepted
2023-11-09 17:16:22
Documents
69
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1329235
2 ex10-3.htm EX-10.3 5462
3 ex10-5.htm EX-10.5 1775
4 ex31-1.htm EX-31.1 17596
5 ex31-2.htm EX-31.2 18358
6 ex32-1.htm EX-32.1 7056
7 ex32-2.htm EX-32.2 7285
8 ex10-3_001.jpg GRAPHIC 230762
9 ex10-3_002.jpg GRAPHIC 177143
10 ex10-3_003.jpg GRAPHIC 213877
11 ex10-3_004.jpg GRAPHIC 164552
12 ex10-3_005.jpg GRAPHIC 63041
13 ex10-5_001.jpg GRAPHIC 218308
14 ex10-5_002.jpg GRAPHIC 94081
  Complete submission text file 0001493152-23-040115.txt   8226600

Data Files

Seq Description Document Type Size
15 XBRL SCHEMA FILE lixt-20230930.xsd EX-101.SCH 47757
16 XBRL CALCULATION FILE lixt-20230930_cal.xml EX-101.CAL 33898
17 XBRL DEFINITION FILE lixt-20230930_def.xml EX-101.DEF 226090
18 XBRL LABEL FILE lixt-20230930_lab.xml EX-101.LAB 405161
19 XBRL PRESENTATION FILE lixt-20230930_pre.xml EX-101.PRE 315493
63 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1092529
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39717 | Film No.: 231393770
SIC: 2834 Pharmaceutical Preparations